Publications in collaboration with researchers from Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (1)

2020

  1. Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Standard of Care in Latin America for Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Propensity Score Matching Analysis

    Advances in Therapy, Vol. 37, Núm. 12, pp. 4996-5009